We are live on ! Find out more
DCM

Decade Capital Management Portfolio holdings

AUM $463M
1-Year Est. Return 13.43%
This Fund
S&P 500
This Quarter Est. Return
-7.18%
1 Year Est. Return
+13.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$463M
AUM Growth
-$364M
Cap. Flow
-$327M
Cap. Flow %
-70.63%
Top 10 Hldgs %
34.88%
Holding
175
New
39
Increased
34
Reduced
44
Closed
55

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$23.6M
2
CPHD
Cepheid Inc
CPHD
+$11M
3
GHDX
Genomic Health, Inc.
GHDX
+$10.8M
4
CFG icon
Citizens Financial Group
CFG
+$10.6M
5
ASB icon
Associated Banc-Corp
ASB
+$9.92M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$30.4M
2
SHPG
Shire pic
SHPG
+$23.5M
3
HAL icon
Halliburton
HAL
+$19.1M
4
HUM icon
Humana
HUM
+$18.7M
5
IQV icon
IQVIA
IQV
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 37.97%
2 Financials 30.79%
3 Real Estate 12.02%
4 Consumer Discretionary 10.17%
5 Materials 0.19%

No holdings matched the selected filter criteria.

3 4 5 6 7

Similar funds

CWA
Convergent Wealth Advisors Potomac, Maryland $442M AUM 7.38% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
BACM
Blue Arrow Capital Management New York $369M AUM 18.08% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
CCM
Catapult Capital Management New York $265M AUM 21.83% 1-Year Est. Return
LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return

Decade Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Decade Capital Management held 175 positions worth $463M, down 44% from $828M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Decade Capital Management withdrew a net $327M in Q3 2015, closing 55 positions and reducing 44 holdings. Its most notable exit was Halliburton, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Decade Capital Management opened a new position in Boston Scientific worth $22.6M.

  • Decade Capital Management's largest Q3 2015 buy was Boston Scientific: 1,378,016 shares worth $22.6M.
  • Decade Capital Management added most to KeyCorp in Q3 2015, an estimated $7.06M increase.
  • Decade Capital Management's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $30.4M.
  • Decade Capital Management fully exited Halliburton in Q3 2015, selling an estimated $19.1M.
  • Decade Capital Management's ten largest holdings make up 35% of its $463M portfolio in Q3 2015.
  • Decade Capital Management opened 39 new positions and closed 55 in Q3 2015.
  • Decade Capital Management's portfolio value fell 44% quarter-over-quarter to $463M.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.